Nrupen Bhavsar, PhD

Assistant Professor in Medicine
Assistant Professor in Biostatistics and Bioinformatics
Associate of the Duke Initiative for Science & Society
Campus mail Ste 500 NC Mutual Mldg, Box 104427, Durham, NC 27710
Phone (919) 668-7211
Email address nrupen.bhavsar@duke.edu

I am a quantitative epidemiologist with methodological expertise in the design and analysis of observational studies that leverage data from cohort studies, registries, and the electronic health record (EHR). My background, training, and research is in the measurement and characterization of biomarkers, risk factors and treatment outcomes for chronic disease using real-world datasets. My primary research interests are in the use of novel sources of data, including the EHR, to conduct chronic disease research at the intersection of informatics, biostatistics, and epidemiology. My ongoing work aims to integrate informatics, epidemiology, and biostatistics to reduce the burden of chronic disease. I have topical expertise in multiple chronic diseases, including oncology, cardiovascular disease, and chronic kidney disease. In parallel, I have a portfolio of research that aims to understand the impact of social determinants of health, including dynamic neighborhood changes, such as gentrification, on the health of adults and children. 

Education and Training

  • Fellowship, Johns Hopkins University School of Medicine, 2011 - 2013
  • Fellowship, New York University School of Medicine, 2010 - 2011
  • Ph.D., Johns Hopkins University, 2010

Publications

Bhavsar, Nrupen A., Anna Köttgen, Josef Coresh, and Brad C. Astor. “Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.” Am J Kidney Dis 60, no. 2 (August 2012): 233–40. https://doi.org/10.1053/j.ajkd.2012.02.336.

PMID
22542304
Full Text

Pollack, Craig E., Gary Noronha, Gene E. Green, Nrupen A. Bhavsar, and H Ballentine Carter. “Primary care providers' response to the US Preventive Services Task Force draft recommendations on screening for prostate cancer.” Arch Intern Med 172, no. 8 (April 23, 2012): 668–70. https://doi.org/10.1001/archinternmed.2012.135.

PMID
22529237
Full Text

Bhavsar, Nrupen A., Lawrence J. Appel, John W. Kusek, Gabriel Contreras, George Bakris, Josef Coresh, Brad C. Astor, and Brad C. AASK Study Group. “Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.” Am J Kidney Dis 58, no. 6 (December 2011): 886–93. https://doi.org/10.1053/j.ajkd.2011.07.018.

PMID
21944667
Full Text

O’Seaghdha, Conall M., Shih-Jen Hwang, Nrupen A. Bhavsar, Anna Köttgen, Josef Coresh, Brad C. Astor, and Caroline S. Fox. “Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population.” Am J Kidney Dis 57, no. 6 (June 2011): 841–49. https://doi.org/10.1053/j.ajkd.2010.11.022.

PMID
21292366
Full Text

Astor, Brad C., Anna Köttgen, Shih-Jen Hwang, Nrupen Bhavsar, Caroline S. Fox, and Josef Coresh. “Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study.” Am J Nephrol 34, no. 4 (2011): 291–97. https://doi.org/10.1159/000330699.

PMID
21829008
Full Text

Song, Danny Y., Travis L. Thompson, Viswanathan Ramakrishnan, Rachel Harrison, Nrupen Bhavsar, Onajite Onaodowan, and Theodore L. DeWeese. “Salvage radiotherapy for rising or persistent PSA after radical prostatectomy.” Urology 60, no. 2 (August 2002): 281–87. https://doi.org/10.1016/s0090-4295(02)01709-0.

PMID
12137827
Full Text

Pages